Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial - Concepedia

Concepedia

Publication | Closed Access

Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial

311

Citations

29

References

2016

Year

David F. Penson, Andrew J. Armstrong, Raoul S. Concepcion, Neeraj Agarwal, Carl A. Olsson, Lawrence I. Karsh, Curtis Dunshee, Fong Wang, Kenneth K. Wu, Andrew Krivoshik,

Journal of Clinical Oncology

Abstract

Enzalutamide significantly reduced risk of prostate cancer progression or death compared with bicalutamide in patients with nonmetastatic or metastatic CRPC.

References

	Year	Citations

Page 1